文献库搜索 | GeneLibs

Edelman(M J),Bisaccia(S),Smith(R),Lesko(S)... J Clin Oncol 0000-00-00

...ERCC1, beta tubulin III and RRM1.,Patients with Stage III or IV NSCLC undergoing therapy were evaluated utilizing the Bl...

Yang(D Y),Vallböhmer(D),Rhodes(K E),Zhang(... J Clin Oncol 0000-00-00

...ERCC1, GSTP1) are associated with the clinical outcome of patients with CRC treated with first-line 5-FU/Leucovorin/CPT-...

Fakih(M G),Rajput(A),Yang(G Y),Pendyala(L)... J Clin Oncol 0000-00-00

...ERCC1 by RT-PCR and for TS, TP, DPD, and apoptosis by IHC. Baseline and changes in expression were correlated with patho...

Kwok(S Y),Kim(W),Tom(S),Christopherson(C),... J Clin Oncol 0000-00-00

...ERCC1, ERCC2 and GSTP1 have been reported to predict response of colorectal cancer (CRC) to 5FU, irinotecan and oxalipla...

Grau(J J),Palmero(R),Monzo(M),Alos(L),Nava... J Clin Oncol 0000-00-00

5547 Background: Single nucleotide polymorphisms (SNPs) correlate with response to chemotherapy. ERCC1 and XPD are DNA r...

Mehmood(R K),Sales(K M),Dijk(S),Winslet(M ... J Clin Oncol 0000-00-00

...ERCC1has demonstrated cisplatin resistance. We want to compare the levels of XPA and ERCC1 gene expression in oesophagea...

Keam(B),Keam(B),Han(S W),Ham(H S),Kim(D W)... J Clin Oncol 0000-00-00

...ERCC1 (118C/T, C8092A), GSTP1 Ile105Val, and XPD (Lys751Gln, Asp312Asn, 156C/A). Response rate (RR), time-to-progression...

Rosell(R),Cobo(M),Isla(D),Massuti(B),Monte... J Clin Oncol 0000-00-00

...ERCC1 is a leading component of NER in repairing cis damage. Increased ERCC1 mRNA levels have been related to resistance...

Shahnam(Adel),Ridha(Zainab),Wiese(Michael ... Pharmacogenomics 0000-00-00

...ERCC1, ERCC2, XRCC1, GSTP1 and GSTM1 genes may be contributing factors. Additionally, the effect of these genotypes may ...

Zhang(Aihua),Li(Huiyao),Xiao(Yun),Chen(Lip... Biomarkers 0000-00-00

...ERCC1, ERCC2 and XPC genes in peripheral blood lymphocytes (PBLs) and skin lesions of arsenicosis patients and NaAsO-tre...